搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
i
23 分钟
How a plaster made of human tissue could treat heart attacks
Previous attempts to use cell therapies have failed - but early results using a new type of muscle patch look promising ...
45 分钟
7 Big Questions About Cancer, Answered
Can pollution cause it? What about inflammation? And how do tumors spread? Here’s what scientists are learning about this ...
STAT
45 分钟
Engineered muscle patch fixed failing hearts in an early study
In "remarkable" work, a patch of engineered heart muscle cells was used to strengthen a patient's heart before transplant.
1 小时
on MSN
Gene therapy and bone marrow transplant alleviate ultra-rare genetic disease symptoms
In two new papers, researchers from The Jackson Laboratory (JAX) report the successful use of two approaches—gene therapy and ...
1 小时
on MSN
A cure for HIV: 'One of the hardest goals in science'
Curing HIV will be harder than curing cancer. But new research is promising.HIV is "like a time bomb," said James Riley, a ...
1 小时
Stem Cell Factor (SCF) Market: Forecast to Grow at a 11.4% CAGR, Driven by Recombinant ...
Market is Segmented by Type (Recombinant, Native), by Application (Hematopoietic Stem Cell Research and Treatment, Cancer Research and Treatment).
Multiple Sclerosis News Today
1 小时
New immune biomarkers uncovered with foralumab treatment
Intranasal foralumab can modulate a number of immune cell types in people with non-active SPMS, developer Tiziana Life ...
News Medical
2 小时
Exploring the interaction between cell death and cellular senescence in cancer
Aging cells secrete substances known to promote the growth of cancer cells. The development of drugs that can selectively kill these cells or inhibit the secretion of substances is ongoing.
Targeted Oncology
2 小时
FDA Grants Orphan Drug Designation to MB-105 for R/R T-Cell Lymphoma
MB-105, a first-in-class CD5-targeted CAR T-cell therapy, received FDA orphan drug designation for relapsed/refractory T-cell ...
labiotech
2 小时
Pancreatic cancer: Oncolytics Biotech, Candel, and CytomX bring promising therapies to the ...
Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...
2 小时
VectorBuilder Powers FDA IND Approval of World’s First Umbilical Cord Blood-Derived ...
VectorBuilder's partner, Ucello, announced that its CD19-targeting umbilical cord blood-derived allogeneic CAR-T cell therapy ...
drugtargetreview.com
4 小时
Cilta-cel: A new era in multiple myeloma treatment
New cell therapy, Cilta-cel, shows promise in the treatment of multiple myeloma, providing a personalised approach with the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈